Home/Filings/4/0001214659-23-003694
4//SEC Filing

Marshall Ken W. 4

Accession 0001214659-23-003694

CIK 0001398733other

Filed

Mar 8, 7:00 PM ET

Accepted

Mar 9, 3:07 PM ET

Size

5.6 KB

Accession

0001214659-23-003694

Insider Transaction Report

Form 4
Period: 2023-03-09
Marshall Ken W.
Commercial Leader
Transactions
  • Award

    Common Stock

    2023-03-09+150,000150,000 total
Holdings
  • Common Stock

    (indirect: By Trust)
    1,445
Footnotes (1)
  • [F1]The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Issuer

Aquestive Therapeutics, Inc.

CIK 0001398733

Entity typeother

Related Parties

1
  • filerCIK 0001740092

Filing Metadata

Form type
4
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 3:07 PM ET
Size
5.6 KB